Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Suppressing very long chain fatty acids is linked to skin cancer.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

FDG PET/CT scans can change cancer treatment plans for dogs.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.